Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : LSI Corporation -- Ignore unavailable to you. Want to Upgrade?

To: shane forbes who wrote (18896)	6/15/1999 5:49:00 PM
From: shane forbes	Respond to of 25814

Ran out of time: What I also keep track of is the total gains I have made since inception. This number is the key. This number divided by your average portfolio value through the years is as good an indicator as any - though you have to be careful to adjust for big changes in portfolio values. -- ending song: Repeat 14-- 'The base revenues for LSI were $1.85 billion in 1998. Except for a IPR&D accounting writeoff (bogus), the Symbios assets that LSI bought were not subsequently written off. What did take place was a $5.4 million Symbios Integration Accrual. Per the 10-K, page 42, this accrual comprised '$4 million related to involuntary separation and relocation benefits for approximately 300 Symbios positions and $1.4 million in other exit costs primarily relating to the closing of Symbios sales offices and the termination of certain contractual relationships.' Therefore it appears that the $75 mil restructuring charge taken later was for the 'old LSI' and has very little negative bearing on Symbios continuing operations. LSI valued Symbios at a fair value of $804 million - $324 million for tangible assets, $214 million for current technology, $37 million for assembled workforce and trademarks, $83 million for goodwill, and $146 million for IPR&D (this part was written off). In this context, $5.4 million is puny and irrelevant. Symbios' assets (read: ability to generate revenue) only strengthened after integration with LSI. They did not weaken. Further, LSI has not indicated that they discontinued anything significant in the Symbios product line. Because they used purchase accounting (versus pooling) LSI can't use pro-forma Q1, Q2, Q3 or full-year 1998 numbers going forward. It is NOT because, as Jock mumbles grandiosely: "It would be a terrible disservice to the company, shareholders, and the public in general.". Give me a freakin' break.' ---

To: shane forbes who wrote (18896)	6/15/1999 5:51:00 PM
From: shane forbes	Respond to of 25814

From Briefing.com: LSI Logic Corp. (LSI) 43 11/16 +5/16: Lehman Bros raises target price on manufacturer of semiconductor products and storage systems solutions from $50 to $66 as analyst believes demand is robust and earnings will exceed estimates..... <yawn, double yawn, and triple yawn - just get me to my magic carpet ride> [BTW note the description they give LSI - semiconductor PRODUCTS and STORAGE SYSTEM SOLUTIONS. A good thing.] -- ending song: Repeat 15-- 'The base revenues for LSI were $1.85 billion in 1998. Except for a IPR&D accounting writeoff (bogus), the Symbios assets that LSI bought were not subsequently written off. What did take place was a $5.4 million Symbios Integration Accrual. Per the 10-K, page 42, this accrual comprised '$4 million related to involuntary separation and relocation benefits for approximately 300 Symbios positions and $1.4 million in other exit costs primarily relating to the closing of Symbios sales offices and the termination of certain contractual relationships.' Therefore it appears that the $75 mil restructuring charge taken later was for the 'old LSI' and has very little negative bearing on Symbios continuing operations. LSI valued Symbios at a fair value of $804 million - $324 million for tangible assets, $214 million for current technology, $37 million for assembled workforce and trademarks, $83 million for goodwill, and $146 million for IPR&D (this part was written off). In this context, $5.4 million is puny and irrelevant. Symbios' assets (read: ability to generate revenue) only strengthened after integration with LSI. They did not weaken. Further, LSI has not indicated that they discontinued anything significant in the Symbios product line. Because they used purchase accounting (versus pooling) LSI can't use pro-forma Q1, Q2, Q3 or full-year 1998 numbers going forward. It is NOT because, as Jock mumbles grandiosely: "It would be a terrible disservice to the company, shareholders, and the public in general.". Give me a freakin' break.' ---

To: shane forbes who wrote (18896)	6/15/1999 6:11:00 PM
From: dr_elis	Read Replies (2) \| Respond to of 25814

Mr. Forbes and Mr. Hutchinson, how about a sudden end to your dispute? Its getting boring and unproductive instead of being brilliant and informative (as they were so often before you two started this childish battle). Michael Baier

To: shane forbes who wrote (18896)	6/15/1999 6:23:00 PM
From: sea_biscuit	Read Replies (1) \| Respond to of 25814

The way I look at it is -- I sold some shares, and after taxes, commissions etc., I have some profits left. I divide this amount by the remaining shares that I have, to give me the extent by which they can go down from their cost basis before I just break even. Of course, I ignore the capital loss advantage that I will get if I did sell the remaining shares at a price below their cost price. If I factored that, things would be even better in reality for me than what my method says.